UNSPSC 51262902: Flusoxolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1GPL60IRCI. European Medicines Agency schedules Flusoxolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07753MIG. Flusoxolol generally arises in the molecular formula C22H30FNO4.

UNSPSC 51262902 Flusoxolol, a Commodity code, does not align with state and local procurement activity currently tagged under it. The single recent opportunity on file—Seminole County, Florida's IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2023)—involves pharmaceutical products and medical equipment for community health initiatives, not flusoxolol. The mismatch between the code's nominal scope and the work actually being solicited suggests either a classification error in the source data or minimal recent activity under this code's intended commodity definition.

Absent additional recent opportunities aligned with the flusoxolol Commodity code, this code shows little relevant activity for state and local business development purposes. Practitioners should verify UNSPSC classification accuracy with issuing bodies or rely on broader Family or Class codes when pursuing pharmaceutical procurement opportunities in state and local markets.